Home » Interviews » Kromek Group Record profits and growth set to continue through 2020 (Interview)
Kromek Group

Kromek Group Record profits and growth set to continue through 2020 (Interview)

Kromek Group plc (LON: KMK) CEO Arnab Basu joins DirectorsTalk to discuss its interim results for the six months ended 31 October 2019. Arnab explains to us where its growth has come from, other highlights we should note for the period and what we should expect from the company going forward.

Kromek Group plc is a technology group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride (“CZT”) and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

The Group’s products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

The Group’s business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits (“ASICs”).

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

Currently, the Group has over one hundred full-time employees across its global operations.